Oscar HealthOSCR
OSCR
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
44% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 68
39% more call options, than puts
Call options by funds: $78M | Put options by funds: $56.2M
4.62% more ownership
Funds ownership: 87.35% [Q3] → 91.97% (+4.62%) [Q4]
9% less funds holding
Funds holding: 281 [Q3] → 256 (-25) [Q4]
26% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 77
32% less capital invested
Capital invested by funds: $3.83B [Q3] → $2.62B (-$1.21B) [Q4]
33% less funds holding in top 10
Funds holding in top 10: 12 [Q3] → 8 (-4) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$16
23%
upside
Avg. target
$16
23%
upside
High target
$16
23%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
Wells Fargo Stephen Baxter 32% 1-year accuracy 12 / 37 met price target | 23%upside $16 | Equal-Weight Downgraded | 13 Mar 2025 |
Financial journalist opinion
Based on 10 articles about OSCR published over the past 30 days
Positive
Zacks Investment Research
6 days ago
Why Oscar Health, Inc. (OSCR) Outpaced the Stock Market Today
In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $14.19, denoting a +1.65% change from the preceding trading day.

Positive
Zacks Investment Research
1 week ago
Is Trending Stock Oscar Health, Inc. (OSCR) a Buy Now?
Oscar Health (OSCR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Negative
Zacks Investment Research
1 week ago
Oscar Health, Inc. (OSCR) Advances But Underperforms Market: Key Facts
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $12.85, representing a +0.16% change from its previous close.

Neutral
Zacks Investment Research
2 weeks ago
Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why
Oscar Health, Inc. (OSCR) reachead $13.45 at the closing of the latest trading day, reflecting a +1.74% change compared to its last close.

Positive
CNBC Television
2 weeks ago
Here's how Oscar Health CEO Mark Bertolini wants to fix the health insurance system
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, discusses potential solutions to some of the problems in the health insurance industry and why he believes the individual insurance market is the solution for Americans.

Positive
CNBC Television
2 weeks ago
Oscar Health CEO on fixing the health insurance system: Individual insurance market is the solution
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, joins 'Squawk Box' to discuss potential solutions to some of the problems in the health insurance industry, why he believes the individual insurance market is the solution for Americans, and more.

Positive
Seeking Alpha
3 weeks ago
Oscar Health: The Most Undervalued Small Cap But With One Big Risk
I am bullish on Oscar Health (OSCR) due to its efficient D2C model, AI integration, and improving EBITDA margins despite high revenue growth. OSCR's opportunity in the ICHRA market is significant, with projections to increase 3x-5x by 2030, positioning it well against larger competitors. Risks include potential changes to ACA subsidies under future administrations, which could disrupt OSCR's current business model and force a shift to ICHRA.

Neutral
Business Wire
3 weeks ago
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point, Thiel Bio, Founders Fund, Bertelsmann Investments, and existing investors, Giant Ventures and Obvious Ventures. The round also received backing from angel investors and healthcare pioneers, including Mario Schlosser, co-founder and former CEO of Oscar Health (NYSE: OSCR), Ryan Fukushima, COO of Tempus,.

Neutral
Accesswire
4 weeks ago
Oscar Health, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - OSCR
NEW YORK, NY / ACCESS Newswire / March 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning possible violations of federal securities laws. Oscar Health reported mixed earnings performance for the fourth quarter including a greater than expected loss of $0.62 per share.

Neutral
Accesswire
4 weeks ago
Oscar Health, Inc. (OSCR) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oscar Health, Inc. ("Oscar Health, Inc.") (NYSE:OSCR) concerning possible violations of federal securities laws. Oscar Health reported mixed earnings performance for the fourth quarter including a greater than expected loss of $0.62 per share.

Charts implemented using Lightweight Charts™